Holen Sie sich die Stockscreener-App
0.7974
7.15%
0.051
Schlusskurs vom Vortag:
$0.7464
Offen:
$0.74
24-Stunden-Volumen:
479.54K
Relative Volume:
0.73
Marktkapitalisierung:
$61.30M
Einnahmen:
$208.00K
Nettoeinkommen (Verlust:
$-23.45M
KGV:
-0.5987
EPS:
-1.3319
Netto-Cashflow:
$-16.38M
1W Leistung:
+22.95%
1M Leistung:
+33.30%
6M Leistung:
-38.00%
1J Leistung:
-44.84%
1-Tages-Spanne:
$0.74
$0.8351
1-Wochen-Bereich:
$0.6302
$0.8351
52-Wochen-Spanne:
$0.3625
$1.91
Envoy Medical Inc Stock (COCH) Company Profile
Firmenname
Envoy Medical Inc
Sektor
Branche
Telefon
651-361-8000
Adresse
4875 WHITE BEAR PARKWAY, WHITE BEAR LAKE
Compare COCH vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
COCH
Envoy Medical Inc
|
0.7974 | 57.38M | 208.00K | -23.45M | -16.38M | -1.3319 |
|
ABT
Abbott Laboratories
|
108.49 | 187.91B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
339.20 | 129.05B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
87.25 | 112.19B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
69.50 | 101.72B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
81.89 | 49.14B | 6.07B | 1.06B | 1.34B | 1.8063 |
Envoy Medical Inc Stock (COCH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-06-24 | Eingeleitet | Ascendiant Capital Markets | Buy |
Envoy Medical Inc Aktie (COCH) Neueste Nachrichten
Envoy Medical Completes Enrollment for Acclaim Fully Implanted Cochlear Implant Trial - The Hearing Review
Enrollment Complete in Study Evaluating Fully Implanted Cochlear Implant - Medical Product Outsourcing
First fully implanted cochlear implant trial hits key U.S. milestone - Stock Titan
EXCLUSIVE: Envoy Medical Hits Trial Milestone For Cochlear Implant Designed To Work With Natural Ear - Benzinga
Quarterly Trades: Is Envoy Medical Inc showing insider buyingCEO Change & Scalable Portfolio Growth Methods - baoquankhu1.vn
COCH Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
COCH Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Envoy Medical Regains Nasdaq Listing Compliance After Financing - TipRanks
Envoy Medical (NASDAQ: COCH) regains compliance with Nasdaq listing rule - Stock Titan
Revenue Check: Can Envoy Medical Inc Equity Warrant be the next market leaderQuarterly Performance Summary & Real-Time Chart Pattern Alerts - baoquankhu1.vn
Envoy Medical secures three new patents, bolstering cochlear implant leadership - Indian Pharma Post
Envoy Medical Nears Enrollment Completion for Acclaim Cochlear Implant Trial - The Hearing Review
Envoy Medical regains Nasdaq compliance after balance sheet work - Investing.com Australia
Envoy Medical (COCH) Price Target Increased by 15.15% to 9.69 - Nasdaq
Envoy Medical regains Nasdaq compliance after balance sheet work By Investing.com - Investing.com South Africa
COCHW Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Envoy Medical Regains Compliance with Nasdaq Listing Requirement - TMX Newsfile
Nasdaq clears Envoy Medical after $35M value shortfall - Stock Titan
Envoy Medical receives three new patents for cochlear implant tech By Investing.com - Investing.com India
Envoy Medical receives three new patents for cochlear implant tech - Investing.com Australia
Envoy Medical Secures Three New Patents Strengthening Competitive Position in the Fully Implanted Hearing Space - marketscreener.com
Does Envoy Medical Inc. stock benefit from AI growthTrade Analysis Summary & High Win Rate Trade Alerts - mfd.ru
What are analysts’ price targets for Envoy Medical Inc.July 2025 Rallies & Free Accurate Trade Setup Notifications - mfd.ru
Envoy Medical Provides Business Update Following Transformative Financing and Positive Progress in Clinical Trial - The Globe and Mail
Envoy Medical raises $30 million, nears completion of cochlear implant trial By Investing.com - Investing.com South Africa
Analyzing Envoy Medical (NASDAQ:COCH) and TearLab (OTCMKTS:TEAR) - Defense World
Envoy Medical raises $30 million, nears completion of cochlear implant trial - Investing.com Nigeria
Fully implanted cochlear implant nears trial end as Envoy's $30M financing lands - Stock Titan
Glen Taylor Buys 241% More Envoy Medical Shares - simplywall.st
Envoy Medical interim CFO buys $85k in shares - Investing.com Nigeria
Envoy Medical interim CFO buys $85k in shares By Investing.com - Investing.com Canada
Glen Taylor buys $7.5m in Envoy Medical (COCH) stock - Investing.com
Glen Taylor buys $7.5m in Envoy Medical (COCH) stock By Investing.com - Investing.com Australia
Envoy Medical (COCH) investor details 84.8% beneficial ownership stake - Stock Titan
Envoy Medical Nears Completion of Enrollment in Pivotal Clinical Trial of Fully Implanted Acclaim(R) Cochlear Implant - marketscreener.com
Can Envoy Medical Inc. Equity Warrant continue delivering strong returnsMarket Growth Report & Capital Protection Trade Alerts - mfd.ru
Envoy Medical shares skyrocket after FDA clears final stage of pivotal Acclaim® cochlear implant trial - MSN
Envoy Medical Closes Upsized Public Offering to Fund Growth - TipRanks
Envoy Medical Signs Multiple Financing Agreements - TradingView
Is Envoy Medical Inc. Equity Warrant stock gaining market share2025 Dividend Review & Daily Profit Maximizing Tips - mfd.ru
Envoy Medical Announces Closing of Up to $78.0 Million Upsized Public Offering - TradingView
Is Envoy Medical Inc. stock risky to hold now2025 Technical Patterns & Daily Growth Stock Investment Tips - mfd.ru
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
Envoy Medical Grants Stock Options to Key Executives - TipRanks
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
Envoy Medical Announces Pricing of Up to $78.0 Million Upsized Public Offering - TMX Newsfile
Finanzdaten der Envoy Medical Inc-Aktie (COCH)
Umsatz
Nettogewinn
Free Cashflow
ENV
Envoy Medical Inc-Aktie (COCH) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Potashnick Robert | Interim CFO |
Feb 12 '26 |
Buy |
0.40 |
212,500 |
85,000 |
212,500 |
| Kantor Susan | Director |
Feb 12 '26 |
Buy |
0.40 |
96,150 |
38,460 |
174,037 |
| BRYNELSEN CHARLES | Director |
Feb 12 '26 |
Buy |
0.40 |
1,000,000 |
400,000 |
1,050,000 |
| Lucas Brent T. | Chief Executive Officer |
Feb 12 '26 |
Buy |
0.40 |
62,500 |
25,000 |
297,090 |
| TAYLOR GLEN A | 10% Owner |
Feb 12 '26 |
Buy |
0.40 |
18,750,000 |
7,500,000 |
21,703,607 |
| Patel Mona Chetan | Director |
Jun 11 '25 |
Buy |
1.47 |
2,500 |
3,675 |
20,000 |
| Patel Mona Chetan | Director |
Jun 06 '25 |
Buy |
1.46 |
10,000 |
14,600 |
17,500 |
| BRYNELSEN CHARLES | Director |
May 27 '25 |
Buy |
1.65 |
35,000 |
57,673 |
50,000 |
| BRYNELSEN CHARLES | Director |
May 23 '25 |
Buy |
1.64 |
13,000 |
21,363 |
15,000 |
| BRYNELSEN CHARLES | Director |
May 22 '25 |
Buy |
1.68 |
2,000 |
3,367 |
2,000 |
0.93%
0.75%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):